Takayanagui 1992.

Methods	Controlled clinical trial Duration: dates not stated, follow up for 6 months
Participants	Number: 59 Inclusion criteria: parenchymal non‐enhancing cystic lesions Exclusion criteria: lesions with enhancement, encephalitic cysticercosis, intraventricular cysts
Interventions	Group 1: Praziquantel daily doses 50 mg/kg for 21 days Group 2: Albendazole daily doses 20 mg/ kg for 21 days Group 3: No antihelmintic
Outcomes	Number of cysts before and 6 months after treatment, adverse events
Notes	Location: Brazil Source of funding: not stated